Monoclonal antibodies which promote central nervous system remyelination

Moses Rodriguez; David J. Miller

doi:10.1016/S0734-9750(97)88700-9

Monoclonal antibodies which promote central nervous system remyelination

Moses Rodriguez, David J. Miller

Neurology

Research output: Contribution to journal › Article › peer-review

Abstract

Monoclonal IgM antibodies which promote central nervous system remyelination when given to a mammal afflicted with a demyelinating disease are disclosed. These antibodies show multi-organ autoreactivity, and recognize both surface and cytoplasmic determinants on glial cells.

Original language	English (US)
Pages (from-to)	775
Number of pages	1
Journal	Biotechnology Advances
Volume	15
Issue number	3-4
DOIs	https://doi.org/10.1016/S0734-9750(97)88700-9
State	Published - 1997

ASJC Scopus subject areas

Biotechnology
Bioengineering
Applied Microbiology and Biotechnology

Access to Document

10.1016/S0734-9750(97)88700-9

Cite this

@article{cf0f03bc4f0a4d8b9fa0f520a7dd87cb,

title = "Monoclonal antibodies which promote central nervous system remyelination",

abstract = "Monoclonal IgM antibodies which promote central nervous system remyelination when given to a mammal afflicted with a demyelinating disease are disclosed. These antibodies show multi-organ autoreactivity, and recognize both surface and cytoplasmic determinants on glial cells.",

author = "Moses Rodriguez and Miller, {David J.}",

year = "1997",

doi = "10.1016/S0734-9750(97)88700-9",

language = "English (US)",

volume = "15",

pages = "775",

journal = "Biotechnology Advances",

issn = "0734-9750",

publisher = "Elsevier Inc.",

number = "3-4",

}

TY - JOUR

T1 - Monoclonal antibodies which promote central nervous system remyelination

AU - Rodriguez, Moses

AU - Miller, David J.

PY - 1997

Y1 - 1997

N2 - Monoclonal IgM antibodies which promote central nervous system remyelination when given to a mammal afflicted with a demyelinating disease are disclosed. These antibodies show multi-organ autoreactivity, and recognize both surface and cytoplasmic determinants on glial cells.

AB - Monoclonal IgM antibodies which promote central nervous system remyelination when given to a mammal afflicted with a demyelinating disease are disclosed. These antibodies show multi-organ autoreactivity, and recognize both surface and cytoplasmic determinants on glial cells.

UR - http://www.scopus.com/inward/record.url?scp=0030692543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030692543&partnerID=8YFLogxK

U2 - 10.1016/S0734-9750(97)88700-9

DO - 10.1016/S0734-9750(97)88700-9

M3 - Article

AN - SCOPUS:0030692543

SN - 0734-9750

VL - 15

SP - 775

JO - Biotechnology Advances

JF - Biotechnology Advances

IS - 3-4

ER -

Monoclonal antibodies which promote central nervous system remyelination

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this